Peter Connolly

Peter Connolly is an accomplished professional in the field of structural biology and biophysics, currently serving as Vice President at Expansion Therapeutics since November 2020, after previously holding positions as Senior Director of Structural Biology and Consultant. Connolly's extensive experience includes over 14 years at Vertex Pharmaceuticals as a Research Fellow, focusing on the structure determination of target proteins using multidimensional heteronuclear NMR and NMR-detected fragment screening. Prior roles at UCB Research and UCB Pharma as Principal Scientist involved similar responsibilities in protein structure determination and fragment library design. Connolly's career began at the Rowland Institute for Science, where contributions included studying protein structure, dynamics, and folding. Peter Connolly holds a Ph.D. in Chemistry from Boston College, earned in 1987.